Predictive Multimodal Signatures Associated With Response to Treatment and Prognosis of Patients With Stage IV Non-small Cell Lung Cancer
Clinical trial NCT04994795 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04994795
- Sponsor
- Sophia Genetics SAS
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2021-08-21
- Primary completion
- 2024-12-01
- Enrollment
- 4000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.